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Abstract
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Introduction:
Increasing number of diseases including Alzheimer’s disease [1], transmissible prion disorders
[2], type II diabetes are linked to amyloid fibrils [3]. The mechanism of amyloid fibril formation
starting from the monomer is still poorly understood. During the cascade of events in the transi-
tion from monomers to mature fibrils a number of key intermediates, namely, soluble oligomers
and protofilaments are populated. It is suspected that the conformations of the peptides in
these aggregated state differ substantially from the isolated monomer which implies that the
monomer undergoes substantial inter-peptide interaction-driven structural transformations [4].
The need to understand the assembly kinetics of fibril formation has become urgent because of
the realization that soluble oligomers of amyloidogenic peptides may be even more neurotoxic
than the end product, namely, the amyloid fibrils [5]. In order to fully understand the routes
to fibril formation one has to characterize the major species in the assembly pathways. The
characterization of the energetics and dynamics of oligomers (dimers, trimers etc) is difficult
using experiments alone because they undergo large conformational fluctuations. In this con-
text, carefully planned molecular dynamics simulation studies [6, 7, 8, 9], computations using
coarse-grained models [10], and bioinformatic analysis [11, 12] have given considerable insights
into the early events in the route to fibril formation. Here, we describe progress along this
direction using examples taken largely from our own work.
In this chapter, we focus on the following aspects of protein aggregation using Aβ-peptides
and prion proteins as examples.
• What are the plausible scenarios in the transition from monomers to amyloid fibril forma-
tion?
•What features of the amyloidogenic peptides control the growth kinetics of fibrils? Although
the assembly mechanism is complex the overall growth kinetics is determined largely by the
charge states and hydrophobicity of the monomers.
• Can sequence and structural analysis be used to predict specific patterns that are likely to
be susceptible to aggregation? By exploiting the sequence profiles and structures of the cellular
form of prions, PrPC , we uncover the regions that are likely to trigger the large conformational
changes in the transition from PrPC to the scrapie form, PrPSc.
• Is there an organizational principle in oligomer and fibril formation? The formation of
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morphologically similar aggregates by a variety of proteins that are unrelated in sequence or
structure suggests that certain general principles may govern fibrillization. However, the vast-
ness of sequence space and the heterogeneity of environmentally-dependent interactions make
deciphering the principles of aggregation difficult. Nevertheless, we will argue that oligomers
and higher order structures form in such a way that the number of intra- and inter-molecular
hydrophobic interactions are maximized and electrostatic repulsions are minimized. The latter
implies that the motifs that minimize the number of salt bridges are preferred.
For the issues raised above we formulate tentative ideas using phenomenological arguments
and atom molecular dynamics (MD) simulations. Using a number of experimental observations
and results from computer simulations certain general principles of amyloid formation seem to
be emerging. There are a number of unresolved issues that remain despite significant progress.
A few of these are outlined at the end of the paper.
Scenarios for peptide-association:
The molecular details of the cascade of events that lead to the formation of amyloid fibrils
remain unknown because the species along the aggregation pathways are highly dynamic and
metastable. Indeed, AFM images of protofibrils show that they undergo shape fluctuations which
implies a heterogeneous population of species. A number of experimental studies suggest that
fibril formation exhibits all the characteristics of a nucleation growth process. It is suspected
that the formation of a critical nucleus is the rate determining step in the fibril formation [13].
Once the critical nucleus, whose very nature might be both depend on sequence as well as
external conditions, forms the fibril formation process is essentially downhill in free energy. The
nucleation characteristics manifests themselves in the appearance of a lag phase in the fibril
formation. The lag phase disappears if a seed or a preformed nucleus is present in the saturated
peptide solution. The seeded growth of fibrils has also been observed in simple lattice and off-
lattice models of protofibril formation. From this perspective the general scenario for explaining
aggregation kinetics is in place. However, the details of the process including the dependence of
the growth kinetics on the specifics of the sequence are not fully understood.
Here we present two extreme scenarios [14] that describe the needed conformational changes
in monomers that lead to a population of species that can nucleate and grow. The two potential
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scenarios, which follow from the energy landscape perspective of aggregation, differ greatly in
the description of the dynamics of the monomers. It was advocated early on that fibrillization
requires partial unfolding of the native state [15] or partial folding of the unfolded state (see
Scenario I in Fig. (1)). Both events, which are likely to involve crossing free energy barriers lead
to the transient population of the assembly-competent structures N∗. The better appreciated
possibility is Scenario I in which environmental fluctuations (pH shifts for example) produces
spontaneously the N∗ conformation. For example, extensive experiments [16] have shown that
the N∗ state in transthyretin (TTR), which has a higher free energy than the native state N,
formed upon unraveling of the strands C and D at the edge of the structure. This process
exposes an aggregation-prone strand B. One can also envision a scenario in which N∗ has a
lower free energy than N thus making the folded (functional state) state metastable. It is likely
that amyloidogenic proteins, in which nearly complete transformation the structure takes place
upon fibrillization, may follow the second scenario. In both cases fibrillization kinetics results
from the ability to populate the N∗ species. In either scenarios (TTR aggregation that follows
Scenario I or PrP Sc formation that follows scenario II) growth kinetics is initially determined
by the ’unfolding’ barriers separating N∗ from either N or U. The energy-landscape perspective
for aggregation (Fig. (1)) suggests that the free energy of stability may not be a good indicator
of fibril growth kinetics. Rather, growth kinetics should correlate with unfolding barriers.
In scenario I, the amyloidogenic state N∗ is formed by denaturation stress or other environ-
mental fluctuations. The production of N⋆ in scenario II can occur by two distinct routes. If N
is metastable, as is apparently the case for PrPc [17], then conformational fluctuations can lead
to N⋆. Alternatively, formation of N⋆ can also be triggered by intermolecular interactions. In
the latter case N⋆ can only form when the protein concentration exceeds a threshold value. As
noted below there is evidence for both scenarios in the routes to fibril states.
In order to understand the kinetics of fibrillization it is necessary to characterize the early
events and pathways that lead to the formation of the critical nucleus. In terms of the energy
landscape, the structures of N⋆, the ensemble of transition state structures, and the conforma-
tions of the critical nuclei must be known to fully describe the assembly kinetics. Teplow and
coworkers, who have followed the growth of fibrils for eighteen peptides, including Aβ1−40 and
Aβ1−42 [18] showed that the formation of amyloids is preceded by the transient population of the
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intermediate oligomeric state with high α-helical content. This is remarkable given that both
the monomers and fibrils have little or no α-helical content. Therefore, the transient formation
of α-helical structure represent an on-pathway intermediate state.
Somewhat surprisingly, we found using multiple long MD simulations that in the oligomer-
ization of Aβ16−22 peptides [6] the oilgomer assembles into antiparallel β-structure upon inter-
peptide interactions. Even in the oligomerization of these small peptides from the Aβ family the
assembly was preceded by the formation of an on-pathway α-helical intermediate. Based on our
findings and the work by Teplow and coworkers we postulated that the formation of oligomers
rich in α-helical structure may be a universal mechanism for Aβ peptides.
Formation of the on-pathway α-helical intermediate may be rationalized using the following
arguments. The initial events involve the formation of ”non-specific” oligomers driven by hy-
drophobic interactions that reduces the effective available volume to each Aβ peptide. In the
confined space peptides adopt α-helical structure. Further structural changes are determined
by the requirement of maximizing the number of favorable hydrophobic and electrostatic inter-
actions. Provided that Aβ oligomers contains large number of peptides, this can be achieved if
Aβ peptides adopt extended β-like conformations.
There is some similarity between the aggregation mechanism postulated for Aβ peptides
and the nucleated conformational conversion (NCC) model envisioned for the conversion of
Sup35 to [PSI+] in Saccharomyces Cerevisiae [19]. By studying the assembly kinetics of Sup35,
Serio et al. [20] proposed the NCC model, which combines parts of the templated assembly
and nucleation-growth mechanisms. The hallmark of the NCC model [20] is the formation of
a critical sized mobile oligomer, in which Sup35 adopts a conformation that may be distinct
from its monomeric random coil or the one it adopts in the aggregated state. The formation
of a critical nucleus to which other Sup35 can assemble involves a conformational change to
states that it adopts in the self-propagating [PSI+]. The α helical intermediate seen in Aβ
peptides may well correspond to the mobile oligomer that has the ”wrong” conformation to
induce further assembly.
Assembly of Aβ16−22 oligomers:
The Aβ16−22 monomer is a random coil: The small size of Aβ16−22 peptides, which adopt an
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antiparallel β-sheet structure in the fibril state, is an ideal system for exploring in detail the
mechanism of oligomer formation. Using fairly long and multiple trajectories [6], the assembly
pathways for 3 Aβ16−22 → (Aβ16−22)3 were probed using all atom simulations in explicit water.
The simulations of Aβ16−22 and the corresponding mutants allowed us to draw a number of
conclusions that may be of general validity.
The simulations of the Aβ16−22 monomer at room temperature and at neutral pH showed
that it is predominantly a random coil. The finite size of the system gives rise to large
conformational fluctuations that lead to the population of strand-like structures. There is a
very low (∼ 3%) probability of α-helical conformations. The study of this simple system shows
that the β-sheet conformation adopted by the monomer must be due to interactions with other
peptides.
Oligomerization of three Aβ16−22 peptides requires a transient monomeric α-helical intermediate:
Upon interaction with other peptides substantial changes in the conformations of the individual
monomers occur. The size of the monomer increases by about 50%. More surprisingly, we
found that as interpeptide interaction increases there is a dramatic increase in the percentage of
α-helical content during intermediate times. At longer times the monomer undergoes a α → β
transition. Due to the small size of the oligomer (n = 3) there are substantial conformational
fluctuations even after the three strands are roughly in antiparallel registry. Nevertheless, the
simulations showed that the size of the nucleus for Aβ16−22 cannot be large because even with n
= 3 there are signatures of stable oligomers. Indeed, explicit simulations for t > 300 ns show that
one can obtain nearly perfectly aligned Aβ16−22 trimers in which the strands are in antiparallel
registry (Li, private communication). In these simulations < uˆi(t)uˆj(t) > where uˆi(t) is the unit
vector connecting the N and C termini of peptide i fluctuates around values close to -1.
The dominant pathway for 3 Aβ16−22 → (Aβ16−22)3 from the simulations showed that in
the intermediate stages the monomer transiently populates an α-helix (see Fig.(8) from [6]). It
should be emphasized that in the assembly process (especially in the early stages in the oligomer-
ization) there are multiple routes. As a result, kinetic trapping can result in structures that
are not conducive to forming the most stable antiparallel structures. Such kinetically controlled
structures have been explicitly probed in dimer formation of small fragments of Aβ peptides.
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These studies and other simulations illustrate the complexity in dissecting the assembly of even
small amyloidogenic peptides into ordered structures.
The gross features of the fibril structures of a number of proteins and peptides whose monomer
sequences and structures are unrelated are similar. This observation might suggest that the
interactions that stabilize the oligomers and fibrils must be “universal” involving perhaps only
backbone hydrogen bonds. It might appear that side chains, and hence sequence differences,
might play a secondary role. Such a conclusion is further supported by repeated observations [21]
that any protein or peptide can be made to form cross-β structures under appropriate conditions.
However, experiments [22] and simulations [7, 23] show that side chain interactions are crucial
in directing oligomer formation. Trimers of Aβ16−22 are stabilized primarily by favorable inter-
peptide hydrophobic interactions between residues in the central hydrophobic cluster (LVFFA)
and secondary by inter-peptide salt bridge formation between K and E.
The importance of side chains can be demonstrated by examining the effect of mutations
on the trimer formation in Aβ16−22 peptides. We showed using simulations that the mutant
GLVFFAK, which eliminates the formation of intermolecular salt-bridge entirely destabilizes
the trimer. Similarly replacement of L, F, F by S, also destabilizes the trimer. These simulations
show that the sequence plays a key role in the tendency of peptides to form amyloid fibrils.
Although no general role has emerged it seems that sequences with enhanced correlation
between charges [12] or preponderance of contiguous (> 3) hydrophobic residues might be
amenable to amyloid formation on finite time scales.
Dimerization of Aβ10−35 peptides:
Generation of putative dimer structures: In contrast to Aβ16−22 fibrils the longer peptide Aβ10−35
adopts a parallel β-sheet conformation in the amyloid state. It is now suspected that in the fibril
state the monomer is stabilized by an intra-molecular salt bridge between Asp23 and Lys28. In
order for this salt bridge to form there has to be a bend in the monomeric structures involving
the residues VGSN. The importance of a stable turn, which was experimentally determined in
the NMR structures, was emphasized in MD simulations as well.
In a recent study [8], we used a number of computational methods to probe dimer formation.
We first generated a putative set of dimer conformations that is based on shape complementarity.
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The work on Aβ16−22 showed that both inter-peptide hydrophobic interactions and the creation
of favorable electrostatic contacts are required to produce marginally stable oligomers. In order
to dissect their relative importance we generated two homodimer decoy sets by maximizing
the number of contacts between the monomer interfaces. The first 2000 dimer structures of
each set were selected by minimizing the interaction energy between the monomers. In order
to distinguish between desolvation and electrostatic interactions we used two distinct energy
functions. The ϕ-dimer (Fig. (2(a))) minimizes the desolvation energies of the dimer at the
interface whereas the ε-dimer (Fig. (2(b))) corresponds to structures that have the highest
inter-peptide electrostatic interactions. The structure of the ϕ-dimer is dominated by contacts
between hydrophobic segments of the monomers. The hydrophobic core, LVFFA(17-21), and
the hydrophobic C-terminus of both monomers are buried at the dimer interface. The contacts
at the interface of the ϕ-dimer are conserved over the lowest energy dimer structures. The
ε-dimer interface is characterized by electrostatic inter-monomeric interactions, among which
the salt bridge Glu11(A)-Lys28(B) has the largest contribution. Contrary to the ϕ-dimer, the
contacts observed at the ε-dimer interface are not conserved across the set of the low energy
dimers due to the increased specificity and strength of the electrostatic interaction.
Interior of Aβ oligomers is dry: Insights into the assembly mechanism of the ϕ-dimer and
ε-dimer can be obtained from the Potential of Mean Force (PMF). The PMF for the dimerization
process was obtained along the center of mass of the two monomers as the Fig.(3) indicates. For
each free energy profile, one can distinguish three distinct intervals. In the outer interval, the
PMF value is nearly constant, from 6.5 A˚ – 7.0 A˚ to maximum separation, which in our case
is 9.0 A˚. At a distance of 6.5 A˚ for the ε-dimer and 7.0 A˚ for the ϕ-dimer, the first solvation
shells of the monomers come into contact, and for both dimers the energetics of desolvation
of the associating monomers is unfavorable. In the second interval for the ε-dimer, the value
of the PMF continues to increase up to 1.2 kcal/mol at a 3.0 A˚ separation; for the ϕ-dimer,
the potential energy reaches a value of 0.8 kcal/mol at 5.5 A˚, and after that the desolvation is
favorable, ending in an unstable local minimum at 3.0 A˚. For the third interval, from 3.0 A˚ to
0.0 A˚, there is only one solvation shell between the monomers. The water molecules are most
strongly ordered near the monomers through electrostatic interactions and hydrogen bonds. As
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a result, the PMF for the ε-dimer increases sharply between 3.0 A˚ and 1.3 A˚ up to 2.4 kcal/mol.
At contact, the van der Waals attraction predominates, making the overall dimerization process
energetically favorable. For the ϕ-dimer, the solvation shell between the hydrophobic regions
of the monomers is only weakly bound to the solute, and after a small increase in the PMF,
corresponding to the van der Waals attraction, the desolvation is entirely favorable.
If the approach along the center of mass of the monomers approximately represents a
minimum energy path, then the expulsion of water in the ϕ-dimer must be an early event in
the assembly. Explicit simulations for Aβ16−22 oligomers [6] also show that desolvation occurs
early. As a result, the interior of Aβ oligomers is dry.
Hydrophobic interactions between monomers are the driving force in the association of Aβ10−35
peptides into dimers: Comparing the ϕ-dimer ε-dimer models for monomer association, we find
that the former appears to lead to more energetically favorable dimerization than the latter. It
appears to be more efficient to remove the entropically unfavorable structured water between
the opposing hydrophobic regions of the two monomers than to stabilize the monomer solely
through electrostatic interactions. This is in good agreement with the experimental and MD
simulations observation that the mutation E22Q – where a charged glutamic acid residue is
replaced by a polar glutamine residue – increases the propensity for amyloid formation[24, 25].
Molecular dynamics simulations of this increased amyloidogenic activity for the E22Q mutant
peptide led to the conclusion that the water-peptide interaction is less favorable for the mutant
peptide [26]. Following a more detailed analysis of the structure and dynamics of the WT and
E22Q Aβ10−35, it has suggested that a change in the charge state of the peptide, due to the E22Q
mutation, leads to an increase of the hydrophobicity of the peptide that could be responsible
for the increased activity[27].
The time evolution of the ϕ-dimer structure was analyzed and it was observed that the
monomers remain in contact during the simulation. It was shown that the hydrophobic interac-
tion between the monomers of the ϕ-dimer acts as a stabilizing force of the dimer. The “extended
core” region 15–30 of both monomers in the ϕ-dimer makes the principal contribution to the
hydrophobic interaction energy. The ϕ-dimer undergoes internal structural reorganization in
the terminal regions of the monomeric peptides. Our simulations indicate that there is substan-
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tial reorganization of the peptide monomers in the N- and C-terminus regions, as expected for
a dimer weakly and relatively non-specifically stabilized by hydrophobic contacts at the dimer
interface. Importantly, the structure of the central hydrophobic cluster LVFFA region assumes
a conformation similar to that observed for the monomeric peptide in both experiment[28] and
simulation[29]. Our simulations suggest that the preservation of the structure of the LVFFA
central hydrophobic cluster plays an important role in the stabilization of the ϕ-dimer structure.
The finding that the ϕ-dimer may constitute the ensemble of stable Aβ10−35 dimer has
important implications for fibril formation. The initial event in the dimerization involves, in
all likelihood, contacts between the central hydrophobic clusters. In this process, expulsion of
water molecules in the interface might be a key event just as in the oligomerization of Aβ16−22
fragments[6]. Since this process involves cooperative rearrangement of ordered water molecules,
it is limited by an effective free energy barrier. Based on our results, we conjecture that events
prior to the nucleation process themselves might involve crossing free energy barriers which
depend on the peptide-peptide and peptide-water interactions (Fig. (1)).
Initial stages in the PrPC conformational transition:
Prion proteins are extracellular globular proteins which are attached to the plasma membrane
by a GPI anchor. They have been linked to various transmissible spongiform encephalopathies
(TSEs) including the bovine spongiform encephalopathy, the scrapie disease in sheep, and the
Creutzfeldt-Jakob disease in humans. The causative agent in these diseases is believed to be
the aggregated form (PrPSc) of the cellular prion protein (PrPC) [30]. The transition to the
scrapie form involves a large conformational change from the mainly α-helical PrPC to the
PrPSc state that is rich in β-sheet. According to the “protein-only” hypothesis [2] PrPSc serves
as a template in inducing conformational transitions in PrPC that can subsequently be added
to PrPSc. The “protein-only” hypothesis implies that the conformational change leading to
the PrPSc formation from the normal cellular form PrPC may be spontaneous or might involve
interactions with unidentified protein X [31]. Prion proteins, encoded by a single gene, consist of
about 250 residues of which the first 22 form a signal sequence. This is followed by unstructured,
but likely helical, Cu2+ binding octarepeats rich in glycine [2]. The NMR [30, 32, 33] and X-ray
[34] structure of PrPC in various species (human, mouse, syrian hamster, bovine, and sheep)
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shows that the ordered C-terminal part is composed of a short antiparallel β-sheet that contains
8% of the residues in the (90-231) fragment and three helices representing 48% of the secondary
structure (Fig.(4). Fourier transform infrared spectroscopy measurements [35, 36] indicate that
PrPSc(90-231) has 47% β-sheet and 24% α-helical content.
We have suggested using structural, bioinformatic, and molecular dynamics simulations that
formation of PrPSc follows scenario II (see Fig. (1)). This implies that, either spontaneously or
in the presence of a seed of PrPSc, the metastable cellular form, PrPC , undergoes a transition
to the PrPC∗ state that is capable of further aggregating or adding to an already present PrPSc
particle. Experiments [37] and scenarios of protein aggregation [14] suggest the proposal that
the conformational transition involves the formation of PrPC∗ that is more stable than PrPC .
The transition from the metastable PrPC → PrPC∗, which involves crossing a substantial free
energy barrier on the order of 20 kcal/mole [17, 38], results in a state that can nucleate and
polymerize to the protease resistant form. We also identified the putative regions that are
involved in the PrPC → PrPC∗ transition. Comparison of a number of structural characteristics
(such as solvent accessible area, distribution of (Φ,Ψ) angles, mismatches in hydrogen bonds,
nature of residues in local and non-local contacts, distribution of regular densities of amino
acids, clustering of hydrophobic and hydrophilic residues in helices) between PrPC structures
and a databank of ”normal” proteins shows that the most unusual features are found in helix
2 (residues 172-194) followed by helix 1 (residues 144-153) [11]. In particular, the C-terminal
residues in H2 are frustrated in their helical state. Application of the recently introduced notion
of discordance, namely, incompatibility of the predicted and observed secondary structures, also
points to the frustration of H2 not only in the wild type but also in mutants of human PrPC .
This suggests that the instability of PrPC proteins may play a role in their being susceptible to
the profound conformational change.
We showed [11] that, in addition to the previously proposed role for the segment (90-120)
and possibly H1, the C-terminus of H2 and possibly N-terminus may play a role in the α → β
transition. Sequence alignments show that helices in avian prion proteins (chicken, duck, crane)
are better accommodated in a helical state which might explain the absence of PrPSc formation
over finite time scales in these species. From the analysis it is clear that the conformational
fluctuations in the C-terminal end of helix 2 (H2) and in parts of helix 3 (H3) are involved in the
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transition to PrPC∗. Because the stability of PrPC arises from the structures in the C-terminal
end, the transition to PrPC∗ requires global unfolding of PrPC [39] which explains the origin of
the high free energy barrier separating PrPC and PrPC∗ [11]. NMR experiments [37, 40] showed
that conformational fluctuations that originate in the C-terminal part of H2 are essential in the
formation of PrPC∗. Structural and mutational studies have also shown that the relatively short
helix 1 (H1) is stable over a range of pH values and solvent conditions, and hence is unlikely to
undergo conformational change in the transition to PrPC∗ [41, 42, 43].
The required conformational fluctuations in PrPC needed to populate PrPC∗ suggest that
the earliest event involves extensive unfolding of the monomeric PrPC . We used results from
a database search of sequence patterns in helices of PrPC and extensive all atom molecular
dynamics (MD) simulations of helical fragments from the mouse prion protein (mPrPC)
to shed light on the nature of instabilities that drive the PrPC → PrPC∗ transition [44].
Previously MD simulations have been used to probe other structural aspects of prion proteins
including structures of protofibrils [45]. The 10 residue H1, with an unusual sequence pattern
(highly charged and presenting the largest percentage of salt bridges in any α-helix in the
PDB), remains helical for the duration of the simulation (≈ 0.09 µs). The double mutant
(D147A,R151A), which eliminates one of the three salt bridges in H1, is less stable than the
wild type. Multiple MD trajectories of peptides encompassing H2 and H3 (together with their
connecting loop) with intact disulfide bond (Cys179-Cys214) showed that residues in the second
half of H2 clustered around positions 187-188 have large conformational flexibility and non-zero
preference for β-strand or coil-like structures. Instability in H2 propagates to H3 especially
from position 214 onwards. Based on these results, we mapped the plausible structures of the
aggregation prone PrPC∗. Despite the limitations (short simulation time and the expected
variations of results with different force fields) of all atom simulations, different computational
approaches yield qualitatively similar results, namely, the initial conformational transition must
involve at least partial unfolding of parts of H2 and H3.
Bioinformatic Analysis:
Pattern of charges in H1 is rare: The distribution of R(+,−) for the 2103 helices from the
DSMP shows that no other natural sequence has as many (+,-) pairs at positions (i,i+4) as H1
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from PrPC . The search of the entire PDBselect database for the H1 charge pattern shows that
in only 56 (4.6%) sequences this pattern occurs at least once, with the total number of patterns
being 63. If we restrict the search to be the exact pattern of H1, i.e. i = - , i+3 = -, i+4 = +,
i+7 = + and i+8 = - the number of sequences is a mere 23 (or 1.9%). Ziegler et al. [43] arrived
at a similar conclusion based on a H1 pattern search in PDB. The 23 rare sequence fragments
are either α-helical (83%) or in a random coil state (17%). Analysis of the Yeast genome
shows that 828 (or 9.2%) of sequences have the general pattern of H1 with only 253 (2.8%)
having the exact pattern. In the E. Coli genome the numbers are: 158 (3.7%) for the general
charge pattern and 51 (1.2%) for the exact match. These results suggest that the sequence
of H1 in PrPC is unusual not only in its high charge content, but also in the positioning of
charges along the sequence. More importantly, for the 23 proteins with known 3D structures,
the exact charge pattern results overwhelmingly in α-helices. Even more interestingly, analysis
of the 19 sequences with mostly α-helical structure reveals that the majority (88%) of (+,-)
pairs of residues found at positions (i,i+4) form salt bridges. These results indicate that the
unusual stability of the short helix H1 is possibly associated with its ability to form the highly
stabilizing salt bridges involving (i,i+4) residues.
Pattern of hydrophobicity in H2 is rare: There are very few sequences that share the pattern of
hydrophobicity of H2. In PDBAstral40 [46] (proteins in the PDB having at most 40% sequence
similarity) there are only 12 (0.2%) such sequences. In the E Coli genome the number is 46
(1%), while in the Yeast genome it is 122 (1.4%). Inspection of the structures of the 12 proteins
from PDBAstral40, shows that the sequence is never entirely helical! For example, in only 13%
of these proteins the last 5 residues are found in a helix. A characteristic pattern seen in H2
from mammalian prion proteins is TTTT (positions 190-193). In the PDBAstral40 this pattern
occurs in only 18 proteins, including the prion sequence. In an overwhelming number of these
cases (15 of the 18 proteins) the TTTT pattern is found in a strand and/or loop conformation
(irrespective of the identity of the flanking amino acids). These results add further support
to our proposal [11] that the second half of H2 would be better accommodated in non-helical
conformations.
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”Frustrated” secondary structural elements may be harbinger of tendency to polymerize The ease
of aggregation and the morphology of the aggregates depend not only on the protein concen-
tration, but also on other external conditions such as temperature, pH and salt concentration.
Although most proteins can, under suitable conditions, aggregate the observation that several
disease causing proteins form amyloid fibrils under physiologically relevant conditions raises the
question: Is aggregation or the need to avoid unproductive pathways encoded in the primary
sequence itself ? It is clear that sequences that contain a patch of hydrophobic residues are prone
to form aggregates [47]. However, it is known that contiguous patches (three or more hydropho-
bic residues) occur with low probability in globular proteins [48]. For example, sequences with
five hydrophobic residues (LVFFA in Aβ peptide) in a row are not well represented. Similarly,
it is unusual to find hydrophobic residues concentrated in a specific region of helices such as is
found in helix 2 in PrPC [11].
It is natural to wonder if secondary structure elements bear signatures that could reveal
amyloidogenic tendencies. Two studies have proposed that the extent of “frustration” in the
secondary structure elements (SSE) may be harbinger of amyloid fibril formation [11, 49].
Because reliable secondary structure prediction requires knowing the context dependent
propensities and multiple sequence alignments (such as used in PHD, Profile network from
Heidelberg [50]), it is more likely that assessing the extent of frustration in the SSE rather
than analysis of sequence patterns is a better predictor of fibril formation. Frustration in SSE
is defined as the incompatibility of the predicted (from PHD, for example) secondary structure
and the experimentally determined structure [49]. For example, if a secondary structure is
predicted to be in a β-strand with high confidence and if that segment is found (by NMR
or X-ray crystallography) to be in a helix, then the structure is frustrated (or discordant or
mismatched). The α/β discordance, which can be correlated with amyloid formation, can be
assessed using the score Sα/β =
1
L
∑L
i=1(Ri − 5), where Ri is the reliability score predicted by
PHD at position i of the query sequence, 5 is the mean score, and L is the sequence length.
The bounds on Sα/β are 0 ≤ Sα/β ≤ 4 with maximal frustration corresponding to Sα/β =
4. Similarly, the measure Sβ/α gives the extent of frustration of a stretch that is predicted
to be helical and is found experimentally to be a strand. Using Sα/β and other structural
characteristics, one can make predictions of the plausible regions that are most susceptible to
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large conformational fluctuations.
PrPC and Dpl: Using the above concept of SSE frustration the 23 residue sequence (QNNFVHD-
CVNITIKQHTVTTTTK) in mouse PrPC , with a score of 1.83, was assessed to be frustrated
or discordant [11]. Other measures of quantifying the structure also showed that the maximal
frustration is localized in the second half (C-terminal of H2) [11]. The validity of this predic-
tion finds support in the analysis of mutants of the PRNP gene associated with inherited TSEs
(familial CJD, and FFI). According to SWISS-PROT [51] seven disease-causing point muta-
tions (D178N, V180I, T183A, H187R, T188R, T188K, T188A) are localized in H2. We have
used the sequence numbering for the mPrPC . A naive use of propensities to form helices, a la
Chou-Fasman [52], would suggest that with the exception of D178N all other point mutations
should lead to better helix formation. However, the Sα/β scores for the mutants are 1.94, 1.80,
1.30, 1.80, 1.54, 1.94, and 1.94 for D178N, V180I, T183A, H187R, T188K, T188R, and T188A
respectively. Thus, in all these mutants H2 is frustrated making it susceptible to conformational
fluctuations which have to occur prior to fibrillization. The differences in Sα/β , which can be
correlated with local stability, suggest that stability alone might not be a good indicator of the
kinetics of amyloid formation.
The gene coding for the Doppel protein (Dpl), termed Prnd [53], is a paralog of the prion
protein gene, Prnp, to which it has about 25% identity. Normally, Dpl is not expressed in
the central nervous system, but it is up-regulated in mice with knockout Prnp gene. In such
cases, overexpression of Dpl causes ataxia with Purkinje cell degeneration [53], which in turn
can be cured by the introduction of one copy of wild-type PrP mouse gene [54]. NMR studies
of the three-dimensional (3D) structure of mouse Dpl [55] showed that it is structurally similar
to the structure of PrPC (Fig. (5)). However, PrPC and Dpl produce diseases of the central
nervous system using very different mechanisms: PrPC causes disease only after conversion to
the PrPSc form, while simple overexpression of Dpl, with no necessity to form the scrapie form,
causes ataxia. The markedly different disease mechanisms of PrP and Dpl would suggest, in
light of the findings for PrPC , that the mouse Dpl (PDB code 1i17) would not be frustrated.
Indeed, prediction of secondary structure by PHD [50] on mouse Dpl correlates well with the
experimentally derived structure. The only difference between the predicted and the derived
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structure in Dpl is found in the first β-strand region which is predicted to be helical by PHD.
But the corresponding Sβ/α = -3.0 indicating that this α-helix prediction is unreliable as this
sequence has low complexity. Also, the analysis of 1i17 with the WHAT CHECK program [56]
reveals that, on average, there are only 8 unsatisfied buried hydrogen-bond donors/acceptors
representing 7.4% of all residues in mouse Dpl. This is comparable with the average value of
6% found in normal proteins, but it is quite smaller than the 14% value seen in mPrP (PDB
code 1ag2). This analysis rationalizes the lack of observation of scrapie formation in Dpl.
Molecular Dynamics simulations:
Helix 1 in mPrP is stable: In order to dissect the stability of PrPC fragments that were
identified using bioinformatic analysis, we used MD simulations of H1 and H2 and H3 from the
PrPC state. With the exception of residues 150-152, the propensities of the interior residues
for α-helical or β-strand conformations show that the helical structure is overwhelmingly
preferred. The distribution of distances between residues at positions (i,i+4) averaged over the
5 trajectories shows that, with the exception of residues in the second half of H1, the helical
structure is preserved. Snapshots of typical conformations at various moments along one of the
trajectories show that even the C-term end of H1, which becomes disordered after ∼ 12 ns,
returns to the helical conformation towards the end of the run. Small fluctuations in a short
helix are unusual because it is known that isolated helices are at best marginally stable [57, 58].
In order to check if the predicted stability of H1 depends on the force field we generated 2
trajectories for a total of 40 ns using the Charmm27 parameter set with the package NAMD.
The backbone rmsd with respect to the PDB structure stabilizes around 2.5-3.0 A˚ after ∼ 10
ns. The rmsd for the backbone of the 144-149 fragment of the chain remains close to 0.5 A˚ for
the duration of the run which is in very good agreement with the previous set of simulations.
The difference between these two sets of simulations is only in the fraying of the C-terminus
residues. These results, which are consistent with the MOIL simulations, also show that the
fraction of helix content in H1 is high.
Mutations of residues in the second salt bridge (D147-R151) enhance conformational fluctu-
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ations: The pattern searches suggest that the three (i,i+4) salt bridges ((Asp144,Arg148),
(Asp147,Arg151), and (Arg148,Glu152)) in H1 should stabilize the isolated H1. To probe
the importance of the second salt bridge (Asp147,Arg151), we simulated the double mutant
H1[D147A,R151A]. Replacing D and R by A should not compromise the local helical propensity
because Ala is the best helix-former among the amino acids [59]. Consequently, any loss of
stability in the structure can be attributed largely to the loss of the the salt bridge. From rela-
tively long MD simulations for H1[D147A,R151A], we find that the double mutant has increased
conformational flexibility compared to the wild-type chain. Most residues, except position 145,
have non-zero β-strand propensity.
The larger conformational fluctuations result in extended states with only the first turn of the
helix still present. Based on these findings, we conclude that H1[D147A,R151A] populates two
basins of attraction: one that is predominantly α-helical with a radius of gyration ∼ 6 A˚, and the
other being mostly RC with a radius of gyration of ∼ 7.7 A˚. Time evolution of distances between
(i,i+4) residues (data not shown) shows that the conformational change starts towards the C-
terminus part of the sequence and proceeds in a highly cooperative manner. Our findings are in
agreement with recent experiments [43] which showed that the peptide huPrP(140-158)D147A
is destabilized compared to wt-huPrP(140-158). The decreased stability of the mutant could
result in the efficient conversion of PrPC(90-231) to the protease resistant form.
By classifying the structures generated in the MD simulations as helical [6], we find that
the helical fraction, fH , of the mutant is 0.55 while fH for the WT is 0.64. The value of fH is
0.63 using the Charmm parameters. We should emphasize that the absolute values of fH might
be overestimated and could depend upon the force field. However, meaningful conclusions
can be drawn using the relative values. Using the fH values we can estimate the free energy
of stability using ∆F = −RTln( fH
1−fH
). For the WT ∆FWT ∼ -0.37 kcal/mol, whereas for
H1[D147A,R151A] ∆FM ∼ -0.13 kcal/mol. If fH using the Charmm parameter set is used,
then ∆FWT ∼ -0.34 kcal/mol. The relative difference ∆∆F = ∆FWT −∆FM ∼ -0.24 kcal/mol
which arises from the salt bridge formation in WT. Interestingly, this estimate for free-energy
gain due to salt bridge formation is in the range of the values reported in the literature [60].
Second half of H2 is susceptible to conformational fluctuations: The trajectories, obtained using
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the NAMD package for a total of 185 ns, showed a drastic reduction in the amount of helical
structure which is accompanied by an increase in β-strand content. The conformational transi-
tion starts in the second half of H2 and propagates towards its N-terminal, while H3 unwinds
concomitantly at its two ends. The propensities of residues for α-helical or β-strand conforma-
tions show that only positions 178 and 179 (H2) and residues 205 to 212 (H3) maintain their
native α-helical structure. The extent of the conformational transition is also reflected in the
behavior of the backbone rmsd from the PDB structure (1ag2) which increases monotonically
from 3 A˚ to 6 A˚ in about 5 ns and reaches 11 A˚ in the next 70 ns.
The conformational transitions are correlated with an increase in the angle between the axes
of the two halves of H2 which changes from 20o to 90o (in the first 10 ns) followed by rapid
oscillations between these values for the remainder of the trajectory. The transition is initiated
in the second half of H2 where the distances between (i,i+4) positions increase from 5 to 14
A˚ in about 10 ns. At longer time scales (t ∼ 60 ns) the distances between (i,i+4) residues
in the first half of H2 also increase from 5 to 13 A˚. These motions in H2 are correlated with
fluctuations in H3, where the distances between the first four (i,i+4) pairs of residues in H3
and between positions 212 - 218 (with the exception of Cys214) increase from 5 to 13 A˚ in
about 10 ns. Almost complete loss of helical structure occurs towards the end of the trajectory
(Fig.(6)). Thus, the conclusions based on bioinformatic analysis are consistent with the results
of MD simulations.
Proposed structures for PrPC∗: Our simulations [44] and recent experiments [42, 43] strongly
suggest that H1 is unlikely to change conformation in the PrPC → PrPC∗ transition. The most
drastic change occurs in the second half of H2 and parts of H3. Based on the assumption that
alterations in the conformation of H2+H3 do not significantly affect the rest of the protein,
we have constructed a plausible ensemble of structures for PrPC∗ (Fig.(6(b)) and 6(c)). In
PrPC∗(90-231) obtained from the NAMD trajectories (Fig.(6(b))) the helical content is ∼ 20%
(a lower bound), and in PrPC∗(90-231) reached during the MOIL simulations (Fig.6(c)) the
helical content is ∼ 30% compared to 48% in mPrPC(90-231).
The overall characteristics of these structures are consistent with those proposed by James
and coworkers [37]. It remains to be seen if formation of PrPC∗, with fluctuating regions in
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H2+H3, is required for oligomerization of PrPC i.e., if PrPC∗ is an on-pathway monomeric
intermediate on the route to fibrillization. We should emphasize that the conformation of the
prion protein in PrPSc need not coincide with PrPC∗.
Comparison of PrPC∗ structure with the Human prion protein dimer: In an important paper
Knaus et al. [61] announced a 2 A˚crystal structure of the dimeric form of the human prion
protein (residues 90-231). The structure (Fig.(7)) suggest that dimerization occurs by domain
swap mechanisms in which H3 from one monomer packs against H2 from another. In fact, Eisen-
berg and coworkers have suggested that domain swapping mechanism may be a general route of
amyloid fibril formation [62]. The electron density map seems to suggest structural fluctuations
in the residues 189-198 which coincides with the maximally frustrated region predicted theo-
retically. The dimer interface is stabilized by residues that are in H2 in the monomeric NMR
structures. The header of the PDB file of the monomeric structure of human PrPC indicates
that H2 ends at residue 194 and H3 begins at 200. The domain swapped dimer structure shows
that residues 190-198 exist largely in a β-strand conformation. The α→ β transition minimizes
frustration. An implication of the dimer structure is that oligomerization occurs by domain
swapping which in PrPC also might implicate the disulfide bond between Cys residues at 179
and 214. The role of the S-S bond in the PrPSc formation remains controversial. In our full-atom
MD simulations of reduced mouse PrPC (data not published), we found structures that closely
resemble the monomeric structure in this dimer. For example, H1 remains mostly intact, while
H2 breaks into two smaller helices, one running from its normal N-term end to position 187 and
the other being formed by the C-term end residues of the original H2 and residues from the
loop connecting it to H3. These findings suggest that the dimer structure is a likely route to
unfolding and self-assembly of monomeric PrPC .
Sequence pattern matches and long multiple molecular dynamics simulations of helix 1 in
mPrPC using two force fields show that the stability of H1 is due to the formation of stabilizing
internal salt bridges. In view of the high propensity of α-helix observed in the isolated H1 in
conjunction with supporting experimental results [41, 42, 43] it is clear that alterations in the
conformation of H1 are unlikely in the PrPC → PrPC∗ transition.
The predicted tendency for the second half of H2 to be involved in the formation of
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PrPC∗ is also consistent with the observation that a number of mutations at 187 and 188
(H187R, T188R, T188K, and T188A) are associated with various prion diseases. Based on
our findings we proposed that regions 186-190 and 214-226 must play a central role in the
initial stages that involve the PrPC → PrPC∗ transition. The large conformational change
is likely to be accompanied by stretching and rotation of the two halves of H2 and by
the unwinding of the N-terminal end of H3. The formation of the domain swapped struc-
ture in the dimer structure of human PrPC [61] might be facilitated by these large scale motions.
Conclusions
The development of methods to envision the structure of amyloid fibrils has enabled us to
obtain molecular insights into the assembly process itself. Computational and experimental
studies are beginning to provide detailed information, at the residue level, about the regions in
a given protein that harbor amyloidogenic tendencies. We have harnessed these developments to
propose tentative ideas on the molecular basis of protein aggregation. These principles (or, more
precisely, rules of thumb) may be useful in the interpretation and design of new experiments.
Examination of the stable structures of oligomers and fibrils obtained using experimental
restraints and simulations show that these must be stable conformations which maximize the
inter-peptide interactions and minimize electrostatic repulsions. Broadly, this is the only amyloid
self-organization principle (ASOP) that seems to be obeyed. From the ASOP it follows that
the formation of amyloid fibrils should indeed be a generic property of almost all proteins and
peptides under suitable conditions. If this were the case then it is remarkable that in the case
of normal function aggregation is avoided most of the time. The lack of preponderant protein
aggregation may well be due to the efficiency of cleaning mechanisms operating in the cell. This
may explain the lack of aggregation of PrPC∗ under most circumstances. We conjecture that
because of efficient degradation processes only mild sequence constraints are needed to prevent
oligomer formation during the typical life cycle of newly synthesized proteins.
From a biophysical perspective there are a number of open problems. Are there common
pathways involved in the self-assembly of fibrils? Because of the paucity of the structural de-
scription of the intermediates involved in an aggregation process a definitive answer cannot be
currently provided. The energy landscape perspective, summarized briefly in Fig.(1), suggests
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that multiple scenarios for assembly must exist. Although the generic nucleation and growth
governs fibril formation the details can vary considerably. The microscopic basis for the for-
mation of distinct strains in mammalian prions and in yeast prions remains a mystery. Are
these merely associated with the heterogeneous seeds or are there unidentified mechanisms that
lead to their growth? What factors may determine the variations in the fibrillization kinetics
for the wild type and the mutants? A tentative proposal is that the kinetics of polymerization
is determined by the rate of production of N⋆ (Fig. (1)) [63], which in turn is controlled by
barriers separating N and N⋆ [11, 64]. In this scenario the stability of N plays a secondary role.
The generality of this observation has not yet been established. Finally, how can one design
better therapeutic agents based on enhanced knowledge of the assembly mechanism? Even in
the case of sickle cell disease viable therapies began to emerge only long after the biophysical
aspects of gelation were understood [65].
21
[1] Selkoe, D. J. (2001) Physiol. Rev. 81, 741–766.
[2] Prusiner, S. B. (1998) Proc. Natl. Acad. Sci. USA 95, 13363–13383.
[3] Chiti, F & Dobson, C. M. (2006) Ann. Rev. Biochem. 75, 333–366.
[4] Koo, E. H, Lansbury, P. T, & Kelly, J. W. (1999) Proc. Natl. Acad. Sci. USA 96, 9989–9998.
[5] Kayed, R, Head, E, Thompson, J. L, McIntire, T. M, Milton, S. C, Cotman, C. W, & Glabe, C. G.
(2003) Science 330, 486–489.
[6] Klimov, D. K & Thirumalai, D. (2003) Structure 11, 295–307.
[7] Gsponer, J, Haberthur, U, & Caflisch, A. (2003) Proc. Natl. Acad. Sci. USA 100, 5154–5159.
[8] Tarus, B, Straub, J. E, & Thirumalai, D. (2005) J. Mol. Biol. 345, 1141–1156.
[9] Buchete, N. V, Tycko, R, & Hummer, G. (2005) J. Mol. Biol. 353, 804–821.
[10] Dima, R. I & Thirumalai, D. (2002) Prot. Sci. 11, 1036–1049.
[11] Dima, R. I & Thirumalai, D. (2002) Biophys. J. 83, 1268–1280.
[12] Dima, R. I & Thirumalai, D. (2004) Bioinformatics 20, 2345–2354.
[13] Harper, J. D & Lansbury, P. T. (1997) Annu. Rev. Biochem. 66, 385–407.
[14] Thirumalai, D, Klimov, D. K, & Dima, R. I. (2003) Curr. Op. Struct. Biol. 13, 146–159.
[15] Fink, A. L. (1998) Fold. Des. 3, R9–R23.
[16] Kelly, J. W. (1998) Curr. Op. Struct. Biol. 8, 101–106.
[17] Baskakov, I. V, Legname, G, Prusiner, S. B, & Cohen, F. E. (2001) J. Biol. Chem. 276, 19687–
19690.
[18] Kirkitadze, M. D, Condron, M. M, & Teplow, D. B. (2001) J. Mol. Biol. 312, 1103–1119.
[19] Chien, P & Weissman, J. S. (2001) Nature 410, 223–227.
[20] Serio, T. R, Cashikar, A. G, Kowal, A. S, Sawicki, G. J, Moslehi, J. J, Serpell, L, Arnsdorf, M. F,
& Lindquist, S. L. (2000) Science 289, 1317–1321.
[21] F, F. C, Webster, P, Taddei, N, Clark, A, Stefani, M, Ramponi, G, & Dobson, C. M. (1999) Proc.
Natl. Acad. Sci. USA 96, 3590–3594.
[22] Ivanova, I. M, Sawaya, M. R, Gingery, M, Attinger, A, & Eisenberg, D. (2004) Proc. Natl. Acad.
Sci. USA 101, 10584–10589.
[23] Klimov, D. K, Straub, J. E, & Thirumalai, D. (2004) Proc. Natl. Acad. Sci. USA 101, 14760–
22
14765.
[24] Miravalle, L, Tokuda, T, Chiarle, R, Giaccone, G, Bugiani, O, Tagliavini, F, Frangione, B, &
Ghiso, J. (2000) J. Biol. Chem. 275, 27110–27116.
[25] Esler, W. P, Felix, A. M, Stimson, E. R, Lachenmann, M. J, Ghilardi, J. R, Lu, Y. A, V., H. V,
Mantyh, P. W, Lee, J. P, & Maggio, J. E. (2000) J. Struct. Biol. 130, 174–183.
[26] Massi, F & Straub, J. E. (2001) Biophys. J. 81, 697–709.
[27] Massi, F, Klimov, D. K, Thirumalai, D, & Straub, J. E. (2002) Protein Sci. 11, 1639–1647.
[28] Zhang, S, Casey, N, & Lee, J. P. (1998) Fold. Des. 3, 414–422.
[29] Massi, F, Peng, J. W, Lee, J. P, & Straub, J. E. (2001) Biophys. J. 80, 31–44.
[30] Riek, R, Hornemann, S, Wider, G, Billeter, M, Glockshuber, R, & Wuthrich, K. (1996) Nature
(London) 382, 180–182.
[31] Telling, G. C, Scott, M, Mastrianni, J, Gabizon, R, Torchia, M, Cohen, F. E, DeArmond, S. J, &
Prusiner, S. B. (1995) Cell 83, 79–90.
[32] Donne, D. G, Viles, J. H, Groth, D, Mehlhorn, I, James, T. L, Cohen, F. E, Prusiner, S. B, Wright,
P. E, & Dyson, H. J. (1997) Proc. Natl. Acad. Sci. USA 94, 13452–13457.
[33] Zahn, R, Liu, A, Luhrs, T, Riek, R, von Schroetter, C, Garcia, F. L, Billeter, M, Calzolai, L,
Wilder, G, & Wuthrich, K. (2000) Proc. Natl. Acad. Sci. USA 97, 145–150.
[34] Haire, L. F, Whyte, S. M, Vasisht, N, Gill, A. C, Verma, C, Dodson, E. J, Dodson, G. G, &
Bayley, P. M. (2004) J. Mol. Biol. 336, 1175–1183.
[35] Caughey, B. W, Dong, A, Bhat, K. S, Ernst, D, Hayes, S. F, & Caughey, W. S. (1991) Biochemistry
30, 7672–7680.
[36] Gasset, M, Baldwin, M. A, Fletterick, R. J, & Prusiner, S. B. (1993) Proc. Natl. Acad. Sci. USA
90, 1–5.
[37] Kuwata, K, Li, H, Yamada, H, Legname, G, Prusiner, S. B, Akasaka, K, & James, T. L. (2002)
Biochem. 41, 12277–12283.
[38] Baskakov, I. V, Legname, G, Baldwin, M. A, Prusiner, S. B, & Cohen, F. E. (2002) J. Biol. Chem.
277, 21140–21148.
[39] Hosszu, L. P, Baxter, N. J, Jackson, G. S, Power, A, Clarke, A. R, Waltho, J. P, Craven, C. J, &
Collinge, J. (1999) Nature: Struct. Biol. 6, 740–743.
[40] Kuwata, K, O.Kamatari, K, Akasaka, K, & James, T. L. (2004) Biochem. 43, 4439–4446.
23
[41] Liu, A, Riek, R, Zahn, R, Hornemann, S, Glockshuber, R, & Wuthrich, K. (1999) Biopolymers
51, 145–152.
[42] Speare, J. O, III, T. S. R, Bloom, M. E, & Caughey, B. (2003) J. Biol. Chem. 278, 12522–12529.
[43] Ziegler, J, Sticht, H, Marx, U. C, Muller, W, Rosch, P, & Schwarzinger, S. (2003) J. Biol. Chem.
278, 50175–50181.
[44] Dima, R. I & Thirumalai, D. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 15335–15340.
[45] DeMarco, M & Daggett, V. (2004) Proc. Natl. Acad. Sci. USA 101, 2293–2298.
[46] Chandonia, J. M, Walker, N. S, Conte, L. L, Koehl, P, Levitt, M, & Brenner, S. (2002) Nucl.
Acid. Res. 30, 260–263.
[47] West, M. W, Wang, W, Patterson, J, Mancias, J. D, Beasley, J. R, & Hecht, M. H. (1999) Proc.
Natl. Acad. Sci. USA 96, 11211–11216.
[48] Schwartz, R, Istrail, S, & King, J. (2001) Protein Sci. 10, 1023–1031.
[49] Kallberg, Y, Gustafsson, M, Persson, B, Thyberg, J, & Johansson, J. (2001) J. Biol. Chem. 276,
12945–12950.
[50] Rost, B & Sander, C. (1993) J. Mol. Biol. 232, 584–599.
[51] Bairoch, A & Apweiler, R. (2000) Nucl. Acid. Res. 28, 275–284.
[52] Chou, P. Y & Fasman, G. D. (1978) Ann. Rev. Biochem. 47, 251–276.
[53] Moore, R. C, Lee, I. Y, Silverman, G. L, Harrison, P. M, Strome, R, Heinrich, C, Karunaratne, A,
Pasternak, S. H, Chishti, M. A, Liang, Y, Mastrangelo, P, Wang, K, A.Smit, A. F, Katamine, S,
Carlson, G. A, Cohen, F. E, Prusiner, S. B, Melton, D. W, Tremblay, P, Hood, L. E, & Westaway,
D. (1999) J. Mol. Biol. 292, 797–817.
[54] Nishida, N, Tremblay, P, Sugimoto, T, Shigematsu, K, Shirabe, S, Petromilli, C, Erpel, S. P,
Nakaoke, R, Atarashi, R, Houtani, T, Sakaguchi, S, DeArmond, S. J, Prusiner, S. B, & Katamine,
S. (1999) Lab. Invest. 79, 689–697.
[55] Mo, H, Moore, R. C, Cohen, F. E, Westaway, D, Prusiner, S. B, Wright, P. E, & Dyson, H. J.
(2001) Proc. Natl. Acad. Sci. USA 98, 2352–2357.
[56] Hooft, R. W. W, Vriend, G, & Sander, C. (1996) Nature (London) 381, 272–273.
[57] Bundi, A & Wuthrich, K. (1979) Biopolym. 18, 299–311.
[58] Dyson, H & Wright, P. E. (1998) Nat. Struct. Biol. 5, 499–503.
[59] Creighton, T. E. (1993) Proteins: Structures and molecular properties. (W.H. Freeman and
24
Company, New York).
[60] Makhatadze, G. I, Loladze, V. V, Ermolenko, D. N, Chen, X, & Thomas, S. T. (2003) J. Mol.
Biol. 327, 1135–1148.
[61] Knaus, K. J, Morillas, M, Swietnicki, W, Malone, M, Surewicz, W. K, & Yee, V. C. (2001) Nature:
Struct. Biol. 8, 770–774.
[62] Liu, Y, Gotte, G, Libonati, M, & Eisenberg, D. (2002) Nature Struct. Biol. 8, 211–214.
[63] Ramirez-Alvarado, M, Merkel, J. S, & Regan, L. (2000) Proc. Natl. Acad. Sci. USA 97, 8979–8984.
[64] Hammarstrom, P, Jiang, X, Hurshman, A. R, Powers, E. T, & Kelly, J. W. (2002) Proc. Natl.
Acad. Sci. USA 99, 16427–16432.
[65] Eaton, W. A & Hofrichter, J. (1995) Science 268, 1142–1143.
[66] Humphrey, W, Dalke, A, & Schulten, K. (1996) J. Mol. Graph. 14, 33–38.
25
Figure Captions
Fig.1. Schematic diagram of the two plausible scenarios of fibrillization based on free energy
landscape perspective. According to scenario I, the assembly competent state N⋆ is metastable
with respect to the monomeric native stateN and is formed due to partial unfolding. In scenario
II N⋆ is formed upon structural conversion either of the native state N (as in prions) or directly
from the unfolded state U (as in Aβ-amyloid peptides). In both cases proteins (or peptides) in
N⋆ states must coalescence into larger oligomers capable of growth into fibrils.
Fig.2. The putative dimer structures corresponding to the ϕ-dimer (a) and ε-dimer (b),
respectively. The side chains at the dimer interface are depicted explicitly. The positively and
negatively charged, polar, and hydrophobic residues are colored in blue, red, purple, and green,
respectively. The Cα atoms of the monomers A (left) and B (right) are colored in cyan and
yellow, respectively.
Fig.3. The Potential of Mean Force (PMF) is plotted for two different relative orientations
of the monomeric peptide within the dimer. The PMF is computed as a function of the surface
separation, δ = ξ − ξcont, along the distance between the centers of mass (DCOMs) of the two
monomers, where ξ and ξcont are the DCOMs of the two monomers when they are at an arbitrary
separation and in contact, respectively. The profile in blue corresponds to the free energy surface
computed using the ε-dimer as the starting structure. The red curve is similarly computed using
the ϕ-dimer as the starting structure. The difference between the two surfaces suggests that
hydrophobic interactions may be more essential to stabilization of the dimer structure than
electrostatic interactions.
Fig.4. Cartoon representation of the structure of human PrPC (PDB entry 1QLX). The three
helices in the 90-231 ordered region of PrPC are colored in red, while the short β-sheet is in
yellow. The two cysteine residues (179 and 214) involved in the disulfide bond that connect
H2 with H3 are indicated in bond representation and colored in purple. The C-term end of H2
and the N-term end of H3 which we believe to be implicated in the initial stages of the α → β
transition are colored in green. The figure was produced with packages VMD [66] and PovRay
(http://www.povray.org/).
Fig.5. Cartoon representation of the structure of human Doppel protein (Dpl) (PDB entry
1LG4). The three helices in the 24-152 ordered region of Dpl are colored in red. The four cysteine
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residues (94, 108, 140 and 145) involved in the two disulfide bonds that connect H2 with H3
and the loops preceding them are indicated in bond representation and colored in purple. The
figure was produced with packages VMD [66] and PovRay (http://www.povray.org/).
Fig.6. Schematic representation of PrPC → PrPC∗ transition, where the conformation for
PrPC is taken from the PDB file 1ag2 (yellow). The conformations for PrPC∗ contain H1
from 1ag2 while the residues encompassing H2+H3 are shown in a conformation (red) reached
towards the end of our MD simulations using the NAMD package (6(b)) or the simulations using
the MOIL package (6(c)). The schematic PrPC∗ structures are representatives from ensembles
of fluctuating conformations. In the representative PrPC∗ structure obtained using NAMD
simulations the H1 region, together with the adjacent loops and the β-strands, and residues (205-
212) from H3 retain their original conformations and are therefore depicted with same color as
in PrPC . In the MOIL representative PrPC∗ structure the H1 region, together with the adjacent
loops and the β-strands, and residues (175-179), (184-188), (193,194) from H2 and residues (203-
218) from H3 retain their original conformations and are therefore depicted with same color as
in PrPC . The figures are rotated such that the orientation of H1 is the same in all of them. The
figures were produced with packages VMD [66] and PovRay (http://www.povray.org/).
Fig.7. Cartoon representation of the X-ray crystal structure of the human PrPC dimer (PDB
entry 1I4M). For each chain, A and B, the three helices in the 90-231 ordered region of PrPC
are colored in red, while the short β-sheet is in yellow. The two cysteine residues (179 and 214)
involved in the disulfide bond that connect H2 with H3 are indicated in bond representation
and colored in purple. The C-term end of H2 and the N-term end of H3 which we believe to
be implicated in the initial stages of the α→ β transition are colored in green. We notice that,
in contrast to the monomeric PrPC structure from Fig.(4), here this region is no longer entirely
helical, but contains a short stretch of β-strand structure and a shorter helix as well. The figure
was produced with packages VMD [66] and PovRay (http://www.povray.org/).
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